| Developmental Pathways Inc | |
|
14280 E Jewell Ave Ste A, Aurora, CO 80012-7939 | |
| (303) 360-6600 | |
| Not Available |
| Full Name | Developmental Pathways Inc |
|---|---|
| Type | Facility |
| Speciality | Early Intervention Provider Agency |
| Location | 14280 E Jewell Ave Ste A, Aurora, Colorado |
| Accepts Medicare Assignments | Does not participate in Medicare Program. The facility may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013472117 | NPI | - | NPPES |
| 9000169911 | Medicaid | CO |
| Mailing Address | Practice Location Address |
|---|---|
| Developmental Pathways Inc 14280 E Jewell Ave Ste A, Aurora, CO 80012-7939 Ph: () - | Developmental Pathways Inc 14280 E Jewell Ave Ste A, Aurora, CO 80012-7939 Ph: (303) 360-6600 |
News Archive
Young children who do not display an ability to regulate their behavior or to delay gratification in exchange for a larger reward appear predisposed to gain extra weight by their pre-teen years, according to two reports published in the April issue of Archives of Pediatrics & Adolescent Medicine.
A genetic test can help determine in which patients cholesterol-lowering statin drugs might have the most benefit in also reducing the risk of colorectal cancer, a new study from researchers at the University of Michigan Comprehensive Cancer Center finds.
Ruthigen, Inc., a biopharmaceutical company, and Pulmatrix, Inc., a Lexington, Massachusetts based clinical stage biotechnology company, announced today that on March 13, 2015, they have entered into a definitive merger agreement.
A new combination of cancer drugs delayed disease progression for patients with hormone-receptor-positive metastatic breast cancer, according to a multi-center phase II trial. The findings of the randomized study (S6-03) were presented at the 2014 San Antonio Breast Cancer Symposium, held Dec. 6-9, by Kerin Adelson, M.D., assistant professor of medical oncology at Yale Cancer Center and chief quality officer at Smilow Cancer Hospital at Yale-New Haven.
Scientists are eager to make use of stem cells' extraordinary power to transform into nearly any kind of cell, but that ability also is cause for concern in cancer treatment.
› Verified 7 days ago